Index by Author

February 2018, Volume 25, Number 2
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abderrahman, Balkees

    • A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers Endocr Relat Cancer 25 (2) R83-R113, doi:10.1530/ERC-17-0416 first published on 21 November 2017
      OPEN ACCESS ARTICLE

  2. Alzahrani, Ali S

  3. Argyle, D J

  4. Asprino, Paula Fontes

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

B

  1. Barlier, Anne

    • Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms Endocr Relat Cancer 25 (2) T15-T28, doi:10.1530/ERC-17-0266 first published on 5 September 2017

  2. Baxter, Robert C

    • Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation Endocr Relat Cancer 25 (2) 111-122, doi:10.1530/ERC-17-0384 first published on 7 December 2017

  3. Beckers, Johannes

  4. Boikos, Sosipatros A

  5. Brue, Thierry

    • Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms Endocr Relat Cancer 25 (2) T15-T28, doi:10.1530/ERC-17-0266 first published on 5 September 2017

  6. Buishand, F O

C

  1. Cagan, Ross L

  2. Camargo, Anamaria Aranha

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

  3. Capodanno, Y

  4. Castellone, Maria Domenica

    • RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2) Endocr Relat Cancer 25 (2) T105-T119, doi:10.1530/ERC-17-0303 first published on 20 September 2017

  5. Castinetti, Frederic

  6. Cesar, Jônatas

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

  7. Chow, Christopher Y C

    • Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict’s value Endocr Relat Cancer 25 (2) 123-130, doi:10.1530/ERC-17-0396 first published on 20 November 2017
      OPEN ACCESS ARTICLE

  8. Chow, Louis W C

    • Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict’s value Endocr Relat Cancer 25 (2) 123-130, doi:10.1530/ERC-17-0396 first published on 20 November 2017
      OPEN ACCESS ARTICLE

  9. Costa, Frederico Perego

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

  10. Curpan, Ramona F

    • A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers Endocr Relat Cancer 25 (2) R83-R113, doi:10.1530/ERC-17-0416 first published on 21 November 2017
      OPEN ACCESS ARTICLE

D

  1. Das, Tirtha K

  2. Dralle, Henning

F

  1. Faber, Anthony C

  2. Fan, Ping

    • A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers Endocr Relat Cancer 25 (2) R83-R113, doi:10.1530/ERC-17-0416 first published on 21 November 2017
      OPEN ACCESS ARTICLE

  3. Feuchtinger, Annette

  4. Firth, Sue M

    • Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation Endocr Relat Cancer 25 (2) 111-122, doi:10.1530/ERC-17-0384 first published on 7 December 2017

  5. Freitas, Florêncio Porto

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

G

  1. Galante, Pedro Alexandre Favoretto

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

  2. Gopie, Priya

  3. Grey, Joanna

    • Patient quality of life and prognosis in multiple endocrine neoplasia type 2 Endocr Relat Cancer 25 (2) T69-T77, doi:10.1530/ERC-17-0335 first published on 24 October 2017

  4. Grossman, Steven R

  5. Guerin, Carole

    • Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms Endocr Relat Cancer 25 (2) T15-T28, doi:10.1530/ERC-17-0266 first published on 5 September 2017

H

  1. Hawsawi, Yousef M

    • A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers Endocr Relat Cancer 25 (2) R83-R113, doi:10.1530/ERC-17-0416 first published on 21 November 2017
      OPEN ACCESS ARTICLE

  2. Hoff, Paulo Marcelo Gehm

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

I

  1. Irmler, Martin

J

  1. Jordan, V Craig

    • A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers Endocr Relat Cancer 25 (2) R83-R113, doi:10.1530/ERC-17-0416 first published on 21 November 2017
      OPEN ACCESS ARTICLE

K

  1. Kirpensteijn, J

  2. Koyama, Fernanda Christtanini

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

  3. Kügler, Andrea

L

  1. Lacroix, André

    • Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms Endocr Relat Cancer 25 (2) T15-T28, doi:10.1530/ERC-17-0266 first published on 5 September 2017

  2. Lalli, Enzo

  3. Linck, Rudinei Diogo Marques

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

  4. Luconi, Michaela

M

  1. Machens, Andreas

  2. Maximov, Philipp Y

    • A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers Endocr Relat Cancer 25 (2) R83-R113, doi:10.1530/ERC-17-0416 first published on 21 November 2017
      OPEN ACCESS ARTICLE

  3. Mei, Lin

  4. Melillo, Rosa Marina

    • RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2) Endocr Relat Cancer 25 (2) T105-T119, doi:10.1530/ERC-17-0303 first published on 20 September 2017

  5. Meyer, Diogo

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

  6. Mol, J A

  7. Molatore, Sara

  8. Moley, Jeffrey

  9. Mologni, Luca

  10. Moodley, Serisha

  11. Morita, Satoshi

    • Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict’s value Endocr Relat Cancer 25 (2) 123-130, doi:10.1530/ERC-17-0396 first published on 20 November 2017
      OPEN ACCESS ARTICLE

  12. Mulligan, Lois

  13. Mulligan, Lois M

  14. Munirajan, Arasambattu Kannan

  15. Murugan, Avaniyapuram Kannan

N

  1. Neff, Frauke

  2. Ng, Wai-Kuen

    • Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict’s value Endocr Relat Cancer 25 (2) 123-130, doi:10.1530/ERC-17-0396 first published on 20 November 2017
      OPEN ACCESS ARTICLE

P

  1. Pang, L Y

  2. Pellegata, Natalia S

  3. Pintar, John E

    • Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation Endocr Relat Cancer 25 (2) 111-122, doi:10.1530/ERC-17-0384 first published on 7 December 2017

  4. Plaza-Menacho, Ivan

  5. Plaza-Menacho, Iván

R

  1. Redaelli, Sara

  2. Riechelmann, Rachel Simões Pimenta

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

  3. Robledo, Mercedes

  4. Romanet, Pauline

    • Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms Endocr Relat Cancer 25 (2) T15-T28, doi:10.1530/ERC-17-0266 first published on 5 September 2017

  5. Roncaroli, Federico

S

  1. Sabbaga, Jorge

    • TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias Endocr Relat Cancer 25 (2) L1-L5, doi:10.1530/ERC-17-0286 first published on 22 November 2017
      OPEN ACCESS ARTICLE

  2. Scott, Carolyn D

    • Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation Endocr Relat Cancer 25 (2) 111-122, doi:10.1530/ERC-17-0384 first published on 7 December 2017

  3. Scully, Tiffany

    • Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation Endocr Relat Cancer 25 (2) 111-122, doi:10.1530/ERC-17-0384 first published on 7 December 2017

  4. Sebag, Frederic

    • Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms Endocr Relat Cancer 25 (2) T15-T28, doi:10.1530/ERC-17-0266 first published on 5 September 2017

  5. Sedger, Lisa M

    • Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation Endocr Relat Cancer 25 (2) 111-122, doi:10.1530/ERC-17-0384 first published on 7 December 2017

  6. Smith, Steven C

T

  1. Taieb, David

    • Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms Endocr Relat Cancer 25 (2) T15-T28, doi:10.1530/ERC-17-0266 first published on 5 September 2017

  2. Toi, Masakazu

    • Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict’s value Endocr Relat Cancer 25 (2) 123-130, doi:10.1530/ERC-17-0396 first published on 20 November 2017
      OPEN ACCESS ARTICLE

  3. Twigg, Stephen M

    • Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation Endocr Relat Cancer 25 (2) 111-122, doi:10.1530/ERC-17-0384 first published on 7 December 2017

W

  1. Waguespack, Steven G

  2. Weber, Frank

  3. Wells, Samuel A, Jr

    • Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors Endocr Relat Cancer 25 (2) T1-T13, doi:10.1530/ERC-17-0325 first published on 15 November 2017

  4. Wiedemann, Tobias

  5. Winter, Kym

    • Patient quality of life and prognosis in multiple endocrine neoplasia type 2 Endocr Relat Cancer 25 (2) T69-T77, doi:10.1530/ERC-17-0335 first published on 24 October 2017

New Articles: issue in progress

  1. July 2018, 25 (7)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most